Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nelly Weledji"'
Autor:
Roselyn Appenteng, Taylor Nelp, Jihad Abdelgadir, Nelly Weledji, Michael Haglund, Emily Smith, Oscar Obiga, Francis M Sakita, Edson A Miguel, Carolina M Vissoci, Henry Rice, Joao Ricardo Nickenig Vissoci, Catherine Staton
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0201550 (2018)
BACKGROUND:Traumatic brain injuries (TBI) are a significant cause of mortality and morbidity for children globally. Adherence to evidence-based treatment guidelines have been shown to improve TBI outcomes. To inform the creation of a pediatric TBI ma
Externí odkaz:
https://doaj.org/article/5cdb79eebec74e7480da01a913cd01ea
Autor:
Nakisa B. Sadeghi, Judith N. Nielsen, Deanna Sasaki-Adams, Edward Yap, Yueh Z. Lee, Virginia Godfrey, Ilana Galex, Michael P Catalino, Brook A. Mitchell, James Ho, Nelly Weledji, Sofia I. Cabello Bermudez, Nathan Davis, Danielle M. Bush
Publikováno v:
World Neurosurgery. 148:e242-e251
Objective Aneurysmal subarachnoid hemorrhage remains a devastating event with poorly understood pathophysiology. Previous studies have suggested that aneurysm wall inflammation may play a part in the development and potential rupture of aneurysms. Th
Autor:
João Ricardo Nickenig Vissoci, Carolina M. Vissoci, Catherine A. Staton, Henry E. Rice, Taylor Nelp, Michael M. Haglund, Jihad Abdelgadir, Nelly Weledji, Roselyn Appenteng, Francis M. Sakita, Oscar Obiga, Edson Roberto Arpini Miguel, Emily R. Smith
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 8, p e0201550 (2018)
PLoS ONE, Vol 13, Iss 8, p e0201550 (2018)
Background Traumatic brain injuries (TBI) are a significant cause of mortality and morbidity for children globally. Adherence to evidence-based treatment guidelines have been shown to improve TBI outcomes. To inform the creation of a pediatric TBI ma
Autor:
Abigail L. Miller, Sau-Chi B. Yan, Karen Cichowski, Nelly Weledji, Bruce M. Konicek, Eric Legius, Ophélia Maertens, Rachel Ingraham, Jeremy R. Graff, Rebecca Lock
Neurofibromin 1-mutant (NF1-mutant) cancers are driven by excessive Ras signaling; however, there are currently no effective therapies for these or other Ras-dependent tumors. While combined MEK and mTORC1 suppression causes regression of NF1-deficie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49010aee933dcfbbbfd85260a3c13af0
https://lirias.kuleuven.be/handle/123456789/541318
https://lirias.kuleuven.be/handle/123456789/541318